Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Klinische Studie zur kulturell angepassten Ernährung in der PR (PRECISION)

13. November 2026 aktualisiert von: Josiemer Mattei, Harvard School of Public Health (HSPH)

Klinische Studie zu kulturell angepasster Ernährung in PR: Evaluierung einer kulturell informierten nachhaltigen Intervention für eine optimale Ernährung in Puerto Rico (PRECISION)

This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a culturally-appropriate, feasible, and sustainable diet intervention aimed at reducing cardiovascular, type 2 diabetes, and obesity outcomes.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This intervention will culturally tailor a diet to the adult population in Puerto Rico based on staple foods as well as culturally appropriate strategies to reduce cardiometabolic risk factors. Based on preliminary results from studies on the island, investigators will conduct a 24-month, 2-arm intervention among 250-350 adults (125-175 per arm) ages 30-65 living in Puerto Rico with at least 1 of 5 cardiometabolic risk factors. The two arms are (1) intervention group with culturally-tailored portion-control Mediterranean Diet-like advice through monthly individual counseling for 12 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes, vegetable oils, and locally sourced assorted fruit and vegetables for 18 months; (2) control arm with portion-control standard non-tailored nutritional counseling in monthly individual sessions for 12 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18-24, we will monitor behavior maintenance (no food/voucher or counseling), with support from the nutritionist, and cues-to-action texts. Investigators will measure changes in cardiometabolic risk factors and metrics of eating behaviors and psychological factors. The two co-primary outcomes are changes in ASCVD score and cardiometabolic improvement score.

Studientyp

Interventionell

Einschreibung (Geschätzt)

250

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • San Juan, Puerto Rico, 00926
        • Rekrutierung
        • Puerto Rico Consortium for Clinical Investigation
        • Kontakt:
        • Unterermittler:
          • Amarilys F Sylva, PhD

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

30 Jahre bis 65 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  1. Age 30-65y old at the time of enrollment

  2. Non-institutionalized

  3. Living in PR at the time of recruitment and for at least the previous year and not planning to move from the island within the next 3 years

  4. Able to answer questions without assistance

  5. Having a cellphone with the capacity to receive text messages and be willing to receive daily text messages from the study on the designated cellphone number

  6. Having at least one of the following:

    1. elevated BMI
    2. elevated waist circumference
    3. self-reported physician-diagnosed hypertension or use of hypertension medication or measured high blood pressure at the baseline visit
    4. self-reported physician-diagnosed pre-diabetes or measured pre-diabetes at the baseline visit
    5. self-reported physician-diagnosed dyslipidemia or use of lipid-lowering agents or laboratory values confirming dyslipidemia

Exclusion Criteria:

  1. Under 30 or over 65 years of age (on the day of the interview).
  2. Currently not living in Puerto Rico or not lived on the island for at least 1 year or planning to move within 3 years
  3. Institutionalized
  4. Not able to answer questions without assistance
  5. Not having at least 1 of the five listed metabolic criteria
  6. Self-reported physician-diagnosed type 1 or type 2 diabetes or use of diabetes medication (including insulin) or diabetes-diagnosis values confirmed by laboratory
  7. Self-reported pregnancy
  8. Gastrointestinal or chronic condition that would impact eating behaviors or nutritional status
  9. Intolerance or allergies to legumes (i.e.: beans and nuts), vegetable oils (i.e.: corn, olive, canola), or fresh produce
  10. Living with another person participating in the study
  11. Participating in another research study that conflicts with PRECISION

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Verhütung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Verdreifachen

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Intervention

Intervention group will receive culturally-tailored portion-control Mediterranean-like advice through monthly individual counseling for 6 months, reinforced with daily text messages for 12 months, and a monthly household supply of legumes (i.e., beans and peanuts), vegetable oils (i.e., olive oil + a blend of canola and soybean), and locally sourced assorted fruit and vegetables for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no food or counseling) with support from the nutritionist available.

Puerto Rico-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc.

Aktiver Komparator: Control

Control group will receive portion-control standard non-tailored nutritional counseling in monthly individual sessions for 6 months, reinforced with daily text messages for 12 months, and monthly assistance to purchase healthy foods for 18 months. From months 18 to 24, we will monitor maintenance of behavior (no voucher or counseling), with support from the nutritionist available.

Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips included in the My Plate For A Healthy Puerto Rico dietary recommendations.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
10-year risk score for a first atherosclerotic CVD event (ASCVD score)
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in first atherosclerotic CVD event (ASCVD) score; the score is calculated using the Pooled Cohort Equation which accounts for biological sex, age, race, total cholesterol, HDL-C, systolic blood pressure, treatment for high blood pressure, current diabetes diagnosis, and smoking status. Scores are expressed as percentage (0-100) with higher scores indicative of higher 10-year risk for ASCVD event. It is categorized as low-risk <5%; borderline risk 5% to 7.4%; intermediate risk 7.5% to 19.9%; and high risk ≥20%.

6; 12; 18; 24 months
Cardiometabolic Improvement Score (CIS)
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in the score; calculated as the added number of risk factors changed over a predefined value; range of 0 to 10; from less to more improvement.

6; 12; 18; 24 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Changes in diet quality score
Zeitfenster: 6; 12; 18; 24 months

Determine the change in score of short diet quality screener (range 18-54; from lowest to highest quality)

6; 12; 18; 24 months
Changes in diet satisfaction: diet satisfaction scale
Zeitfenster: 6; 12; 18; 24 months

Determine the change in the score of the Diet Satisfaction Questionnaire (DSat-45) (range 45-225; from lowest to highest satisfaction) and its summed seven subscales (ranges 5-40)

6; 12; 18; 24 months
Changes in intake of pre-specified food groups (fruit; vegetables; legumes; oils; meat; fat)
Zeitfenster: 6; 12; 18; 24 months

Determine the change in servings/week of food groups

6; 12; 18; 24 months
Change in levels of waist circumference
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in the value of waist circumference (cm)

6; 12; 18; 24 months
Change in levels of BMI
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in the value of body mass index (kg/m2)

6; 12; 18; 24 months
Change in levels of blood pressure risk factors
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in the value of systolic and diastolic blood pressure (mmHg)

6; 12; 18; 24 months
Change in levels of metabolic risk factors
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in the value of glucose, triglycerides, total cholesterol, LDL, HDL (mg/dL)

6; 12; 18; 24 months
Change in food security status
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in food security status assessed by the USDA Food Security Module

6; 12; 18; 24 months
Change in self-efficacy score
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in self-efficacy score assessed by the Nutritional Self-Efficacy Scale

6; 12; 18; 24 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in social connectedness score
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in social connectedness score from the Social Connectedness Scale/Social Assurance Scale

6; 12; 18; 24 months
Change in social support score
Zeitfenster: 6; 12; 18; 24 months

Estimate the change in social support score from the 12-item Social Support Scale

6; 12; 18; 24 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Ermittler

  • Hauptermittler: Josiemer Mattei, PhD, MPH, Harvard Chan School of Public Health
  • Studienleiter: Amarilys F Sylva, PhD, Puerto Rico Consortium for Clinical Investigations

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

2. Mai 2024

Primärer Abschluss (Geschätzt)

2. Mai 2029

Studienabschluss (Geschätzt)

2. Mai 2029

Studienanmeldedaten

Zuerst eingereicht

14. Juli 2023

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

21. Juli 2023

Zuerst gepostet (Tatsächlich)

27. Juli 2023

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

13. November 2026

Zuletzt verifiziert

1. September 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

IPD will be managed and distributed observing NIH and IRB policies on the dissemination and sharing of research results. Study information and requests for data will be available immediately upon the data being de-identified and properly revised for quality control by contacting study investigators.

IPD-Sharing-Zeitrahmen

10 years

IPD-Sharing-Zugriffskriterien

The requested data will be shared with investigators via a secured, password-protected software website, upon request.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • ICF

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .